Talk:Transcription activator-like effector nuclease
 | Individuals with a conflict of interest, particularly those representing the subject of the article, are strongly advised not to directly edit the article. See Wikipedia:Conflict of interest. You may request corrections or suggest content here on the Talk page for independent editors to review, or contact us if the issue is urgent. |
 | This article is rated B-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||
| ||||||||||||||
 | The Wikimedia Foundation's Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see WP:PAID. For advice about reviewing paid contributions, see WP:COIRESPONSE.
|
note edit
This article could be improved by adding a section on the history of the discovery of TALENs. Biolprof (talk) 21:43, 22 January 2014 (UTC)
Wiki Education assignment: CHEM 378 - Biochemistry Lab edit
This article was the subject of a Wiki Education Foundation-supported course assignment, between 31 January 2022 and 22 May 2022. Further details are available on the course page. Student editor(s): Saucyscience (article contribs).
Mention of the role of AvrBs3 in the history of understanding TALEN? edit
Or is that too detailed? The relevant paper is already submitted as a source. Patwis (talk) 11:15, 25 May 2022 (UTC)
Please translate this sentence to proper English (and define PAM sites) edit
"gRNAs have occasionally limitations regarding feasibility due to lack of PAM sites in the target sequence and even though they can be cheaply produced, the current development lead to a remarkable decrease of cost for TALENs, so that they are in a similar price and time range like CRISPR based genome editing" 162.249.205.250 (talk) 22:38, 24 April 2023 (UTC)